Skip to main content
GutCited

Bacillus coagulans لـ Irritable Bowel Syndrome (IBS)

B

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbacillus\u002Dcoagulans\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

Reduces abdominal pain, bloating, and diarrhea in IBS. Spore-forming nature provides excellent stability and gastric acid survival.

Key Study Findings

Meta-Analysis
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Dose: None مقابل: placebo Outcome: improvement in key IBS symptoms التأثير: None None

المجتمع المدروس: patients with IBS from 32 RCTs evaluating 10 probiotic strains

Randomized Controlled Trial n=61 4 weeks Double-blind
Effects of a Bacillus subtilis HU58 and Heyndrickxia faecalis SC208 spore-forming probiotic formula on gastrointestinal …
Dose: None مقابل: Placebo Outcome: Abdominal pain (NRS) and stool consistency (BSFS) التأثير: None P = 0.003 (pain); P = 0.035 (s

المجتمع المدروس: Adults with diarrhoea-predominant IBS (IBS-D)

Randomized Controlled Trial n=100 12 weeks
Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, …
Dose: None مقابل: Control Outcome: Pain outcomes التأثير: None P < .001

المجتمع المدروس: IBS patients

Meta-Analysis
Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review …
Dose: Various probiotic strains/mixtures مقابل: Placebo Outcome: Outcome-specific efficacy ranking in IBS التأثير: None None

المجتمع المدروس: Adults with IBS (RCTs)

Randomized Controlled Trial 12 weeks Double-blind
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in …
Dose: 20.5% مقابل: placebo Outcome: IBS symptom improvement التأثير: None p = 0.038

المجتمع المدروس: Adults with IBS

Review
Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives.
Dose: None مقابل: None Outcome: colitis/IBD severity التأثير: None None

المجتمع المدروس: None

Key Statistics

3

الدراسات

400

المشاركون

Positive

B

التقييم

Referenced Papers

Beneficial microbes 2019 45 اقتباسات
Beneficial microbes 2019 29 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
1-2 billion CFU/day
ibssupport:
2 billion CFU/day (GBI-30 6086 strain)

الحد الأعلى: Well-tolerated up to 6 billion CFU/day in clinical trials

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive --
None 4 weeks Positive 61
None 12 weeks Positive 100
Various probiotic strains/mixtures -- Positive --
20.5% 12 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

أفضل وقت للتناول: With meals for optimal spore germination and colonization

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Mild gas during initial use (generally less than other probiotics due to spore form)
  • Occasional bloating
  • Rare loose stools

التفاعلات المعروفة

  • Antibiotics (spore form is more resistant than vegetative probiotics, but spacing still recommended)
  • Immunosuppressants (theoretical risk in immunocompromised patients)

الحد الأقصى المسموح به: Well-tolerated up to 6 billion CFU/day in clinical trials

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Bacillus coagulans help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is moderate evidence from clinical studies that Bacillus coagulans may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Bacillus coagulans should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-2 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacillus coagulans?
Reported side effects may include Mild gas during initial use (generally less than other probiotics due to spore form), Occasional bloating, Rare loose stools. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacillus coagulans and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.